By Jonathan Cherkoss
Aug 30, 2021
Oregon voters passed two of the nation’s most sweeping drug policy reform measures in U.S. history in 2020, energizing grassroots organizers in Colorado and across the country. What's next for decriminalization and psychedelics reform in Colorado?
By Shawn Hauser
Aug 25, 2021
Recent NDIN notification objections from the FDA give us more insight into the agency's factors differentiating "full spectrum" hemp from CBD.
By Jennifer Cabrera, Heather Kumer, Michelle Bodian, Steve Pemberton, Bridgette Nikisher
Aug 24, 2021
Read this summary to find out what is included, what was left out, and what is noteworthy in New Jersey's recently released cannabis rules.
By Michelle Bodian, Jennifer Cabrera
Aug 11, 2021
New York Gov. Cuomo announced his plans to step down as governor, effective August 24, 2021. On that day, Lieutenant Governor Kathy Hochul will step into the governorship. What will this mean for implementing adult-use cannabis in the Empire State?
By Shane Pennington
Aug 9, 2021
In what could be a groundbreaking case for psychedelic medicine, VS counsel Shane Pennington is part of a team working on an exciting and very important Ninth Circuit challenge to the DEA's refusal to accommodate state and federal right to try laws.
Commentary and analysis on cannabis, hemp, psychedelics, and other emerging therapies from the attorneys and policy specialists at the nation’s leading cannabis law firm.
